The Food and Drug Administration on Monday significantly restricted the use of a pair of monoclonal antibody treatments for COVID-19 because they are ineffective against the omicron.The agency said the therapies made by Eli Lilly and Regeneron…
Copyright © 2024 | WordPress Theme by MH Themes
